This company has been marked as potentially delisted and may not be actively trading. Reliv' International (RELV) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsShort InterestTrendsBuy This Stock RELV vs. DRRX, LGVN, MRKR, LPCN, COCP, CING, GELS, LEXX, BFRG, and PMNShould you be buying Reliv' International stock or one of its competitors? The main competitors of Reliv' International include DURECT (DRRX), Longeveron (LGVN), Marker Therapeutics (MRKR), Lipocine (LPCN), Cocrystal Pharma (COCP), Cingulate (CING), Gelteq (GELS), Lexaria Bioscience (LEXX), Bullfrog AI (BFRG), and ProMIS Neurosciences (PMN). Reliv' International vs. Its Competitors DURECT Longeveron Marker Therapeutics Lipocine Cocrystal Pharma Cingulate Gelteq Lexaria Bioscience Bullfrog AI ProMIS Neurosciences DURECT (NASDAQ:DRRX) and Reliv' International (NASDAQ:RELV) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings. Which has stronger earnings & valuation, DRRX or RELV? Reliv' International has higher revenue and earnings than DURECT. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDURECT$1.86M10.29-$27.62M-$0.15-4.10Reliv' International$35.06M0.13-$440KN/AN/A Do analysts rate DRRX or RELV? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DURECT 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Reliv' International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is DRRX or RELV more profitable? Reliv' International has a net margin of -0.61% compared to DURECT's net margin of -198.58%. Reliv' International's return on equity of -1.89% beat DURECT's return on equity.Company Net Margins Return on Equity Return on Assets DURECT-198.58% -300.62% -65.17% Reliv' International -0.61%-1.89%-1.31% Do institutionals and insiders believe in DRRX or RELV? 28.0% of DURECT shares are owned by institutional investors. Comparatively, 8.0% of Reliv' International shares are owned by institutional investors. 3.2% of DURECT shares are owned by insiders. Comparatively, 31.2% of Reliv' International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, DRRX or RELV? DURECT has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. Comparatively, Reliv' International has a beta of -0.1, meaning that its stock price is 110% less volatile than the S&P 500. Does the media refer more to DRRX or RELV? In the previous week, DURECT had 1 more articles in the media than Reliv' International. MarketBeat recorded 1 mentions for DURECT and 0 mentions for Reliv' International. DURECT's average media sentiment score of 1.89 beat Reliv' International's score of 0.00 indicating that DURECT is being referred to more favorably in the media. Company Overall Sentiment DURECT Very Positive Reliv' International Neutral Does the MarketBeat Community prefer DRRX or RELV? DURECT received 212 more outperform votes than Reliv' International when rated by MarketBeat users. However, 70.27% of users gave Reliv' International an outperform vote while only 60.89% of users gave DURECT an outperform vote. CompanyUnderperformOutperformDURECTOutperform Votes31660.89% Underperform Votes20339.11% Reliv' InternationalOutperform Votes10470.27% Underperform Votes4429.73% SummaryDURECT beats Reliv' International on 8 of the 15 factors compared between the two stocks. Get Reliv' International News Delivered to You Automatically Sign up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RELV vs. The Competition Export to ExcelMetricReliv' InternationalPharmaceutical Preparations IndustryStaples SectorNASDAQ ExchangeMarket Cap$4.64M$6.87B$17.35B$8.50BDividend YieldN/A2.53%3.06%4.16%P/E Ratio-24.188.4316.2119.64Price / Sales0.13262.5243.26152.17Price / Cash44.5365.8516.3934.64Price / Book0.426.536.084.60Net Income-$440K$143.25M$734.57M$248.06M Reliv' International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RELVReliv' InternationalN/A$2.66flatN/AN/A$4.64M$35.06M-24.1891DRRXDURECT1.3453 of 5 stars$0.57+7.3%N/A-63.6%$17.76M$1.86M-0.9480Positive NewsGap DownLGVNLongeveron3.5071 of 5 stars$1.18-5.6%$8.67+634.5%-51.7%$17.62M$2.23M-0.1920Gap DownMRKRMarker Therapeutics4.2636 of 5 stars$1.52+7.8%$13.17+766.2%-60.2%$17.20M$6.59M-1.1460LPCNLipocine2.1534 of 5 stars$3.20-2.4%$9.00+181.3%-61.7%$17.12M$3.67M-4.2110News CoverageAnalyst ForecastAnalyst RevisionGap DownCOCPCocrystal Pharma2.6394 of 5 stars$1.68+1.8%$7.00+316.7%-41.0%$17.09MN/A-0.9110Short Interest ↑CINGCingulate2.0967 of 5 stars$3.98flat$26.00+553.3%+506.1%$16.90MN/A-0.4720Short Interest ↑GELSGelteqN/A$1.79+19.3%N/AN/A$16.89MN/A0.00N/APositive NewsGap DownLEXXLexaria Bioscience2.5133 of 5 stars$0.92-5.7%$7.00+659.9%-70.3%$16.18M$525.92K-1.847News CoverageGap UpBFRGBullfrog AI1.4806 of 5 stars$1.71flatN/A-37.4%$16.10M$60K-2.014News CoveragePositive NewsPMNProMIS Neurosciences2.3303 of 5 stars$0.49-2.0%$4.50+818.4%-68.5%$16.02MN/A-4.905Positive News Related Companies and Tools Related Companies DRRX Competitors LGVN Competitors MRKR Competitors LPCN Competitors COCP Competitors CING Competitors GELS Competitors LEXX Competitors BFRG Competitors PMN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RELV) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reliv' International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reliv' International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
